UA101474C2 - Use of a progesterone in the manufacture of a medicament - Google Patents

Use of a progesterone in the manufacture of a medicament

Info

Publication number
UA101474C2
UA101474C2 UAA200908995A UAA200908995A UA101474C2 UA 101474 C2 UA101474 C2 UA 101474C2 UA A200908995 A UAA200908995 A UA A200908995A UA A200908995 A UAA200908995 A UA A200908995A UA 101474 C2 UA101474 C2 UA 101474C2
Authority
UA
Ukraine
Prior art keywords
progesterone
medicament
manufacture
effacing
cervix
Prior art date
Application number
UAA200908995A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джордж Кризи
Original Assignee
Колумбиа Лабораторис (Бермуда) Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Колумбиа Лабораторис (Бермуда) Лимитед filed Critical Колумбиа Лабораторис (Бермуда) Лимитед
Priority claimed from PCT/GB2008/000397 external-priority patent/WO2008096122A2/en
Publication of UA101474C2 publication Critical patent/UA101474C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

A method for treating or preventing spontaneous preterm birth in pregnant women and improving neonatal morbidity and mortality. The method includes administering to a pregnant woman in need thereof an effective amount of a progesterone sufficient to prolong gestation by minimizing the shortening or effacing of her cervix.
UAA200908995A 2007-02-06 2008-02-05 Use of a progesterone in the manufacture of a medicament UA101474C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88848007P 2007-02-06 2007-02-06
PCT/GB2008/000397 WO2008096122A2 (en) 2007-02-06 2008-02-05 Progesterone for the prevention of preterm birth

Publications (1)

Publication Number Publication Date
UA101474C2 true UA101474C2 (en) 2013-04-10

Family

ID=41595066

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200908995A UA101474C2 (en) 2007-02-06 2008-02-05 Use of a progesterone in the manufacture of a medicament

Country Status (3)

Country Link
CN (1) CN101636166B (en)
UA (1) UA101474C2 (en)
ZA (1) ZA200905726B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012009057A1 (en) * 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotational pessary made from a polymer comprises an active substance against premature births

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060135496A1 (en) * 2004-10-07 2006-06-22 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Also Published As

Publication number Publication date
CN101636166A (en) 2010-01-27
ZA200905726B (en) 2010-05-26
CN101636166B (en) 2013-04-10

Similar Documents

Publication Publication Date Title
MY184866A (en) Progesterone for the treatment or prevention of spontaneous preterm birth
NZ604064A (en) Intravaginal administration of misoprostol
NZ600907A (en) Progestin/estradiol transdermal gel
NZ612717A (en) Treatment of pain associated with dislocation of basal endometrium
PH12014501611A1 (en) Use of specific carbohydrate systems during pregnancy for effecting the offspring
American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 427: misoprostol for postabortion care
MY172530A (en) Method for treating gynecological diseases
UA101474C2 (en) Use of a progesterone in the manufacture of a medicament
Weiss et al. A randomized, double-blind, placebo-controlled trial of relaxin for cervical ripening in post-delivery date pregnancies.
PH12015502160A1 (en) Use of specific carbohydrate systems during pregnancy for preventing fat accumulation in pregnant women
Qing et al. Comparison of oral dydrogesterone and intramuscular progesterone in the treatment of threatened abortion
WO2012058463A3 (en) Trimegestone (tmg) for treatment of preterm birth
Beites et al. Evening primrose oil for cervical ripening
MD335Z (en) Method for preparing the neck of uterus for induction of delivery in pregnants with prolonged pregnancy
MX2010002190A (en) Use of gestagens in combination with (6s)-5-methyltetrahydrofolat e for the therapy of endometriosis with simultaneous reduction of therapy side effects and the reduction of the risk of congenital malformations in case of pregnancy.
Kripke Use of beta agonists in preterm labor
Alkareem et al. Comparison of Different Medical Treatment of Missed Abortion
Sheet Smoking and Infertility
Nikita et al. Mifepristone as pre-induction cervical ripening agent: a review article.
Aponte Low-dose oral contraceptives may be linked to painful orgasm
Shao-Wei et al. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History
Zanguyi et al. A Case Report of Hydatidiform Mole in Fallopian Tube
Ayati Nausea: case report
EA201300484A1 (en) METHOD OF PREVENTION AND TREATMENT OF GESTOSIS IN PREGNANT WOMEN AND DELAYS OF THE DEVELOPMENT OF NEWBORN CHILDREN
UA101133C2 (en) method for preventing complications in the postpartum period in women with fibrocystic disease of the breast